AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PRAZIQUANTEL USP
5 registrations across 3 African markets— 2 active
Markets with PRAZIQUANTEL USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZIQUANTA Film-Coated Tablet | 🇰🇪Kenya | HETERO LABS LIMITED | active | Jan 2030 |
| ZIQUANTA Tablets | 🇷🇼Rwanda | HETERO LABS LIMITED | active | Aug 2029 |
| PRAZIQUANTEL 600MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2021 |
| PRAZIQUANTEL 600MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2013 |
| PRAZIFLAM 600MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2007 |
PRAZIQUANTEL USP in Africa — Regulatory Overview
PRAZIQUANTEL USP is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 2 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.